Trades on 1 secondary market
Amber Bio
Amber Bio is a San Francisco biotechnology company developing an RNA-based gene-editing platform capable of making multi-kilobase edits — rewriting thousands of bases on a single RNA strand in one step — to reach previously undruggable patient populations. Because edited RNA eventually degrades in t
Amber Bio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.